Zinbryta (daclizumab) is a medication used to treat adults with relapsing forms of multiple sclerosis (MS). Multiple sclerosis is a neurological disease that scars nerve tissue and causes a range of symptoms, including pain, vision loss, impaired coordination and paralysis. MS affects more than 2.3 million people worldwide.

Zinbryta is not a cure for MS,